1. Home
  2. EDSA vs VISL Comparison

EDSA vs VISL Comparison

Compare EDSA & VISL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • VISL
  • Stock Information
  • Founded
  • EDSA 2015
  • VISL 2002
  • Country
  • EDSA Canada
  • VISL United States
  • Employees
  • EDSA N/A
  • VISL N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • VISL Telecommunications Equipment
  • Sector
  • EDSA Health Care
  • VISL Telecommunications
  • Exchange
  • EDSA Nasdaq
  • VISL Nasdaq
  • Market Cap
  • EDSA 13.8M
  • VISL 14.9M
  • IPO Year
  • EDSA N/A
  • VISL N/A
  • Fundamental
  • Price
  • EDSA $4.05
  • VISL $6.05
  • Analyst Decision
  • EDSA Strong Buy
  • VISL
  • Analyst Count
  • EDSA 2
  • VISL 0
  • Target Price
  • EDSA $39.00
  • VISL N/A
  • AVG Volume (30 Days)
  • EDSA 13.5K
  • VISL 12.9K
  • Earning Date
  • EDSA 08-09-2024
  • VISL 11-06-2024
  • Dividend Yield
  • EDSA N/A
  • VISL N/A
  • EPS Growth
  • EDSA N/A
  • VISL N/A
  • EPS
  • EDSA N/A
  • VISL N/A
  • Revenue
  • EDSA N/A
  • VISL $32,551,000.00
  • Revenue This Year
  • EDSA N/A
  • VISL $30.41
  • Revenue Next Year
  • EDSA N/A
  • VISL $11.96
  • P/E Ratio
  • EDSA N/A
  • VISL N/A
  • Revenue Growth
  • EDSA N/A
  • VISL 21.75
  • 52 Week Low
  • EDSA $2.50
  • VISL $2.31
  • 52 Week High
  • EDSA $6.46
  • VISL $8.15
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 38.30
  • VISL 45.24
  • Support Level
  • EDSA $4.00
  • VISL $5.81
  • Resistance Level
  • EDSA $4.44
  • VISL $6.40
  • Average True Range (ATR)
  • EDSA 0.25
  • VISL 0.34
  • MACD
  • EDSA -0.03
  • VISL -0.03
  • Stochastic Oscillator
  • EDSA 4.77
  • VISL 24.24

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

About VISL Vislink Technologies Inc.

Vislink Technologies Inc is a technology business specializing in collecting, delivering, and managing high-quality, live video and associated data from the scene of the action to the viewing screen. It provides solutions for the collection of live news, sports, and entertainment events for the broadcast markets. It also furnishes the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The company provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in terrestrial microwave, satellite, fiber optic, surveillance, and wireless communications systems delivering a broad spectrum of customer solutions.

Share on Social Networks: